GENESIS PHARMA (CYPRUS) LTD — Cyprus · TED award notices · Supplier record: 23 award notices, all years (Feb 2024 – Jun 2026); 23 since January 2024 (1 buyer); 12th rank in the line (of 34 suppliers · 4.4%); 2 buyers never served (2 notices in the line from them).
Assay record ASY-CY-05NSSVI0PA · Cite as: Assay Systems, “GENESIS PHARMA (CYPRUS) LTD in the TED register for Cyprus”, https://assay-systems.com/register/cy/genesis-pharma-cyprus-ltd/
23
award notices, all years
Feb 2024 – Jun 2026
23
since January 2024
1 buyer
12th
rank in the line
of 34 suppliers · 4.4%
2
buyers never served
2 notices in the line from them
Own record by year
award notices, 2023 onward
9
11
3
2023202420252026
Who buys from GENESIS PHARMA (CYPRUS) LTD
since January 2024
1buyers
23notices
100%top buyer
Ypourgeio Ygeias100.0%
23 notices
The line
since January 2024
273award notices
3buyers
34suppliers
64.1%held by top ten
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (CPV 33650000)
103
95
75
202420252026Jan–Sep
12thof 34 suppliers
12notices name GENESIS PHARMA (CYPRUS) LTD
4.4%share of the line
4.4%of 271 notices from Ypourgeio Ygeias
8new suppliers since 2025
Buyers that buy the line and never named GENESIS PHARMA (CYPRUS) LTD
Source: contract award notices for Cyprus in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 11 October 2026.Assay Systems has changed the data.